IDH1 and neoplasm: In their observations on 60 patients with astrocytic or oligodendroglial tumors, Saito et al. studied the effect of IDH1 status, 1p19q loss of heterozygosity (LOH), the MIB-1 labelling index, the tumor margin, heterogeneity, and contrast enhancement on MRI scans.